Drug Shortage Report for TEVA-BUDESONIDE
| Report ID | 234891 |
| Drug Identification Number | 02465949 |
| Brand name | TEVA-BUDESONIDE |
| Common or Proper name | BUDESONIDE INH 0.125MG/ML 2ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20pk |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-08 |
| Estimated end date | 2025-12-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v45 | 2025-12-04 | French | Compare |
| v44 | 2025-12-04 | English | Compare |
| v43 | 2025-12-02 | French | Compare |
| v42 | 2025-12-02 | English | Compare |
| v41 | 2025-10-16 | French | Compare |
| v40 | 2025-10-16 | English | Compare |
| v39 | 2025-10-10 | French | Compare |
| v38 | 2025-10-10 | English | Compare |
| v37 | 2025-10-02 | French | Compare |
| v36 | 2025-10-02 | English | Compare |
| v35 | 2025-09-25 | French | Compare |
| v34 | 2025-09-25 | English | Compare |
| v33 | 2025-09-11 | French | Compare |
| v32 | 2025-09-11 | English | Compare |
| v31 | 2025-08-08 | French | Compare |
| v30 | 2025-08-08 | English | Compare |
| v29 | 2025-05-15 | French | Compare |
| v28 | 2025-05-15 | English | Compare |
| v27 | 2025-04-24 | French | Compare |
| v26 | 2025-04-24 | English | Compare |